NCT07453394 2026-03-06
QLS5132 Combination Therapy in Advanced Solid Tumors
Qilu Pharmaceutical Co., Ltd.
Phase 1/2 Not yet recruiting
Qilu Pharmaceutical Co., Ltd.
University of Leeds
AstraZeneca
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
CellCentric Ltd.